As antibody-drug conjugates (ADCs) continue to establish themselves as a cornerstone of modern oncology, breakthrough ...

AstraZeneca's pivot towards the US market has continued with the opening of a new R&D centre in the biotech hotspot of ...

This is not simply a broader role for Market Access. It is an emerging leadership capability for the healthcare business.

Industry is using AI to surface hidden patterns and accelerate decision-making in high-pressure launch environments. In a new ...

The governor of New York has said that rising cases of measles constitute a "statewide disaster emergency," the first such ...

Shares in Vaxcyte have rocketed on the revelation of phase 3 trial data for its pneumococcal vaccine (PCV) candidate VAX-31, ...

Eli Lilly's noncovalent BTK inhibitor Jaypirca has been cleared by the FDA in its first frontline indication for chronic ...

The UK government has said it will accept all 44 recommendations made in a recently published report on using AI tools in the NHS, including continual monitoring after deployment. This morning, the ...

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease, after preliminary results proved disappointing. Shares in ...

The personalized cancer vaccine field has reached a defining milestone. With Moderna and Merck reporting positive initial ...

The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to three scientists – Karl Deisseroth, Peter Hegemann ...

Isao Teshirogi, Shionogi's chief executive. Shionogi has reached a $2 billion agreement to buy Anglo-US biotech IntraBio and ...